BrightGene Bio-Medical Technology Co., Ltd. (SHA: 688166)

BrightGene Bio-Medical Technology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 3, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,372	14,786	9,535	15,051	18,778	13,026
Market Cap Growth	12.69%	55.07%	-36.65%	-19.85%	44.16%	-
Enterprise Value	14,015	15,983	10,606	15,560	18,464	12,865
Last Close Price	29.31	34.91	22.39	36.23	45.09	31.23
PE Ratio	65.29	73.03	39.79	61.70	110.54	117.26
Forward PE	58.33	28.00	28.00	43.06	52.05	85.86
PS Ratio	9.89	12.54	9.37	14.30	23.91	25.89
PB Ratio	5.26	6.12	4.25	8.64	13.11	9.92
P/TBV Ratio	6.46	6.52	4.54	9.47	13.58	10.31
P/OCF Ratio	67.57	75.92	30.63	85.48	120.81	212.37
EV/Sales Ratio	11.29	13.55	10.43	14.79	23.51	25.57
EV/EBITDA Ratio	50.81	58.25	39.13	54.92	86.56	95.93
EV/EBIT Ratio	78.47	76.75	45.84	62.45	100.84	119.18
Debt / Equity Ratio	0.92	0.91	0.90	0.52	0.15	-
Debt / EBITDA Ratio	7.83	7.73	7.17	3.10	1.03	-
Asset Turnover	0.25	0.24	0.27	0.44	0.48	0.44
Inventory Turnover	1.67	1.74	1.63	2.33	2.14	1.56
Quick Ratio	0.99	1.49	1.92	1.23	2.39	8.36
Current Ratio	1.56	1.99	2.39	1.70	3.24	9.81
Return on Equity (ROE)	6.00%	7.44%	10.62%	14.97%	12.34%	10.67%
Return on Assets (ROA)	2.27%	2.69%	3.79%	6.49%	7.04%	5.88%
Return on Capital (ROIC)	2.45%	2.93%	4.19%	7.25%	7.72%	6.48%
Earnings Yield	1.53%	1.37%	2.51%	1.62%	0.90%	0.85%
FCF Yield	-1.12%	-1.41%	-4.36%	-4.87%	-1.06%	-0.22%
Dividend Yield	0.32%	0.28%	0.51%	0.33%	0.19%	0.26%
Payout Ratio	70.90%	56.80%	41.77%	22.26%	20.84%	-
Buyback Yield / Dilution	1.19%	-2.10%	-1.61%	1.87%	-11.90%	-6.22%
Total Shareholder Return	1.52%	-1.82%	-1.10%	2.20%	-11.72%	-5.96%

Source: S&P Capital IQ. Standard template. Financial Sources.